KCT0000426招募中未知
Discovery and validation of genetic markers to establish effective indications of anti-osteoporotic drugs
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 6,604
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational Study
入排标准
- 年龄范围
- 16(Year) 至 100(Year)（—）
- 性别
- All
入选标准
- •Patients who visit Asan Medical Center for osteoporosis and give the informed consent.
- •Patients with measurement of bone mineral density (BMD) for osteoporosis (Classification of case / control group by BMD result)
- •Wahout peroid: Two years using agents more than 6 months against osteoporosis
排除标准
- •1. Subjects within wash-out period
- •2. Secondary osteoporosis: Disorders strongly associated with osteoporosis. These include rheumatoid arthritis, untreated long-standing hyperthyroidism or Graves' disease, chronic liver disease, hyperparathyroidism, and parathyroid adenoma
- •3. Other conditions were not suitable in cohort study: Chronic renal failure, active malignany, and transplantation
研究者
相似试验
已完成
不适用
Genetic study to identify genetic variants which affect clinical severity in Thai patients with beta thalassemia hemoglobin Eclinical variation in patients with beta thalassemia Hb E diseasebeta thalassemia Hb E disease, Thailand, genetic modifierTCTR20211022001Siriraj Hospital338
尚未招募
不适用
Biomarker signature discovery study to determine acute bacterial respiratory tract infection.Respiratory tract infectionNL-OMON56538evels Diagnostics300
进行中（未招募）
1 期
Biomarkers of Response to Pembrolizumab Combined with Chemotherapy in Non-Small Cell Lung Cancer (Keynote-782)EUCTR2018-002598-22-HUMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.100
进行中（未招募）
1 期
Biomarkers of Response to Pembrolizumab Combined with Chemotherapy in Non-Small Cell Lung Cancer (Keynote-782)EUCTR2018-002598-22-ESMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.100
招募中
不适用
Development of molecular diagnostic markers using oral fluid for diagnosis of periodontitis in diabetesDiseases of the musculo-skeletal system and connective tissueKCT0001023Asan Medical Center24